U.S. sent first flight of medical supplies to India for COVID-19 fight
On Apr. 30, 2021, the United States sent its first flight loaded with oxygen cylinders and regulators, N95…
-
-
Lonza and Moderna entered agreement to double drug substance production for COVID-19 vaccine in Visp
On Apr. 29, 2021, Lonza announced the expansion of its collaboration with Moderna to manufacture the drug substance…
-
NIH announced investment of $29 million to address COVID-19 disparities
On Apr. 29, 2021, the National Institutes of Health announced it was funding $29 million in ad itional…
-
BC Study Reports Baby’s first poop predicted risk of developing allergies
On Apr. 29, 2021, researchers at the University of British Columbia (UBC) announced a study published in Cell…
-
Large collaboration created cell atlas of COVID-19 pathology
On Apr. 29, 2021, scientists from several hospitals and research centers reported what happens in individual cells of…
-
Moderna announced an increased global supply for COVID-19 vaccine to up to 3 billion doses in 2022
On Apr. 29, 2021, Moderna announced it was making new funding commitments to increase supply at its owned…
-
Pfizer and BioNTech submitted request to expand conditional marketing authorization of COMIRNATY in EU to adolescents
On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…
-
HHMI announced project to read genomes of all 70,000 vertebrate species
On Apr. 28, 2021, HHMI investigator Erich Jarvis and dozens of colleagues announced they had launched an ambitious…
-
XPhyto pursued market access in Israel for its COVID-19 PCR Rapid Test
On Apr. 28, 2021, XPhyto announce that it has delivered 2,000 of its rapid 25-minute PCR tests (ﾓCovid-ID…
-
VBI Vaccines announced publication of Challenge Study Data of its eVLP vaccine candidate against COVID-19
On Apr. 28, 2021, VBI Vaccines announced that preclinical data of VBIﾒs enveloped virus-like particle (eVLP) vaccine candidate,…
-
Innovation Pharma surpassed 50 percent enrollment in phase 2 clinical trial of Brilacidin for COVID-19
On Apr. 28, 2021, Innovation Pharma announced that enrollment had surpassed 50 percent of the total targeted number…
-
Scientists released error-free genomes of 25 animals with another 70,000 coming up
On Apr. 28, 2021, Rockefeller University researchers announced the launch the Vertebrate Genomes Project, an ambitious initiative launched…
-
CDC | COVID-19 | Infectious Disease | Vaccine
Fully vaccinated adults 65 and older are 94% less likely to be hospitalized with COVID-19
On Apr. 28, 2021, the Centers for Disease Control and Prevention (CDC) announced that both mRNA COVID-19 vaccines…
-
Merck announced licensing agreements with Indian manufacturers to expand access to molnupiravir for treatment of COVID-19
On Apr. 27, 2021, Merck announced the company had entered into non-exclusive voluntary licensing agreements for molnupiravir with…
-
AIM ImmunoTech announced positive safety data in second cohort of phase 1 study Investigating intranasal administration of Ampligen as treatment for COVID-19
On Apr. 27, 2021, AIM ImmunoTech announced that it had completed dosing of Cohort 2 in a Phase…
-
CerTest Biotec, BD announced addition of saliva to CE Marked VIASURE SARS-CoV-2 Real Time PCR Detection Kit for BD MAX
On Apr. 27, 2021, CerTest Biotec, along with BD announced the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | USDA | Vaccine | WHO
COVID-19 science and reason
COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…
-
Gilead Sciences announced steps to expand availability of Remdesivir in India
On Apr. 26, 2021, Gilead Sciences announced that in response to the rapid increase in COVID-19 cases in…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Oncology | Rare Disease | Therapeutics | Vaccine
Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.
On Apr. 26, 2021, Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s…
-
NIH established new childhood asthma clinical research network
On Apr. 23, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had awarded…
-
COVID-19 vaccine responses studied in people with immune deficits
On Apr. 23, 2021, the NIH announced that a study assessing how people with immune system deficiencies or…
-
COVID-19 infections survey revealed significant reductions in COVID-19 infections with single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine
On Apr. 23, 2021, University of Oxford data from the COVID-19 Infection Survey was the first to show…
-
FDA and CDC lifted recommended pause on Johnson & Johnson COVID-19 vaccine
On Apr. 23, 2021, following a thorough safety review, including two meetings of the CDCﾒs Advisory Committee on…
-
INOVIO planned for ex-US global phase 3 trial for INO-4800
On Apr. 23, 2021, Inovio Pharma announced that it was planning for a predominantly ex-U.S. Phase 3 trial…
-
Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients began
On Apr. 22, 2021, the NIH announced that a phase 3 trial to test the safety and efficacy…
-
The WHO announced continued review of emerging evidence on AstraZeneca COVID-19 vaccines
On Apr. 22, 2021, the Strategic Advisory Group of Experts (SAGE) on Immunization annouced updated interim guidance on…
-
Quidel signed retail distribution agreement to increase access to at-home COVID-19 testing
On Apr. 22, 2021, Quidel announced that it had completed a distribution and fulfillment agreement with McKesson to…
-
XPhyto signed German distribution, storage and logistics agreement for 25-minute COVID-19 PCR test
On Apr. 21, 2021, XPhyto announced that it had entered into an agreement with an established German pharmaceutical…
-
Valneva initiated pivotal phase 3 clinical trial for inactivated, COVID-19 vaccine using Dynavax’s CpG 1018ﾙ adjuvant
On Apr. 21, 2021, Dynavax Technologies announced Valneva had initiated a pivotal Phase 3 clinical trial for its…
-
Trevena announced TRV027 selected for study in global REMAP-CAP trial in COVID-19 patients
On Apr. 21, 2021,Trevena announced that TRV027, the Companyﾒs novel AT1 receptor selective agonist, had been selected for…
